Proxy Votes Now

Home › Activist investors › Glenview Capital

Glenview Capital

Other large holder. Positions and campaigns from Glenview Capital’s SEC filings. Updated November 20, 2026.

Filer entities
GLENVIEW CAPITAL MANAGEMENT, LLC
SEC CIK
1138995 (GLENVIEW CAPITAL MANAGEMENT, LLC)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 16, 2026: 135 US-listed positions reported; 5 of 1% or more of a company without a 13D are listed below.
6current positions
5new or changed in 90 days; 1 exited
0active campaigns
1campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (6)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Surgery Partners Inc. 4.98%6,518,188 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Aug 3, 2026 Nov 16, 2026 — — New 13F: none stated
National Vision Holdings, Inc. 3.29%2,603,203 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Jul 31, 2026 Aug 14, 2025 Decreased Nov 16, 2026 ▼ 0.63 pts Decreased 13F: none stated
Global Payments Inc. 2.68%7,105,453 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 30, 2026 May 15, 2014 Decreased Nov 16, 2026 ▼ 0.68 pts Decreased 13F: none stated
Tenet Healthcare 2.57%2,047,843 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 23, 2026 May 15, 2014 Decreased Nov 16, 2026 ▼ 0.20 pts Decreased 13F: none stated
Onto Innovation Inc. 1.19%585,039 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Jul 31, 2026 Nov 14, 2025 Increased Nov 16, 2026 ▲ 0.77 pts Increased 13F: none stated
Butterfly Network, Inc. 6.2%15,120,314 shares Schedule 13D/A, filed Aug 17, 2026 Sep 3, 2024 Decreased Aug 17, 2026 ▼ 2.35 pts — Standard Item 4 language

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Butterfly Network, Inc. · Standard Item 4 language

“Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On June 22, 2026, Mr. Robbins was granted 25,447 shares of unvested restricted stock units, each representing the right to receive one share of Common Stock upon vesting, which vest in full on the date of the Issuer's 2027 Annual Stockholders Meeting, subject to Mr. Robbins' continued service on the Issuer's board of directors…”

Item 4 in the Schedule 13D/A filed Aug 17, 2026.

Summary of the filing Glenview's stake in Butterfly Network fell and it now reports it has ceased to be a beneficial owner of more than five percent of the class, while Item 4 reports only a routine equity grant to its board designee.

Quoted from the filing (item 5): “As of August 13, 2026, Glenview ceased to be the beneficial owner of more than five percent of the class of securities.” Aug 17, 2026

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (1)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Tenet Healthcare No campaign filings in the last 12 months Feb 2, 2018 Jan 19, 2016 Soliciting material filed latest (3) —
Past positions (1)
CompanyLast stakeSourceOutcomeDate
Six Flags Entertainment Corporation 1.97% 13F, quarter ended Jun 30, 2026filed Aug 14, 2026; % of shares outstanding as of Jul 31, 2026 Not in the latest 13F Nov 16, 2026

How large managers voted in Glenview Capital’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

1No outcome in the filings read
Outcome of each campaign (1)
CompanyOutcomeDetailDateFirst filing
Tenet Healthcare No outcome in the filings read — Feb 2, 2018 Jan 19, 2016

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 1 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Glenview Capital’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Surgery Partners Inc. · Glenview Capital first disclosed Nov 16, 2026 · 1 other filing
HolderFormDateStake
King Street Capital Management, L.P. Schedule 13G Aug 14, 2026 4.6%
Six Flags Entertainment Corporation · Glenview Capital first disclosed Feb 17, 2026 · 5 other filings
HolderFormDateStake
Morgan Stanley Schedule 13G Nov 7, 2025 5.6%
JANA Partners 13F Nov 14, 2025 4.6%
Darlington Partners Capital Management, LP Schedule 13G Feb 13, 2026 5.1%
Vanguard Portfolio Management Schedule 13G Apr 29, 2026 5.1%
BlackRock, Inc. Schedule 13G Jul 30, 2026 14.4%
Onto Innovation Inc. · Glenview Capital first disclosed Nov 14, 2025 · 3 other filings
HolderFormDateStake
BlackRock, Inc. Schedule 13G Oct 17, 2025 10.3%
Vanguard Capital Management Schedule 13G Apr 29, 2026 5.2%
Vanguard Portfolio Management Schedule 13G Apr 29, 2026 5.5%
National Vision Holdings, Inc. · Glenview Capital first disclosed Aug 14, 2025 · 6 other filings
HolderFormDateStake
BlackRock, Inc. Schedule 13G Apr 28, 2025 15.4%
Fund 1 Investments, LLC Schedule 13G May 15, 2025 5.7%
Burgundy Asset Management Ltd. Schedule 13G Aug 13, 2025 3.2%
Wellington Management Group LLP Schedule 13G Nov 12, 2025 5.7%
William Blair Investment Management, LLC Schedule 13G Nov 12, 2025 6.2%
American Century Investment Management, Inc. Schedule 13G Nov 14, 2025 5.6%
Butterfly Network, Inc. · Glenview Capital first disclosed Sep 3, 2024 · 1 other filing
HolderFormDateStake
ARK Investment Management LLC Schedule 13G Jan 10, 2025 4.7%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.